You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 7,314,971


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,314,971
Title:Nuclear fertility restorer genes and methods of use in plants
Abstract: The present invention includes nuclear fertility restorer genes, proteins encoded by those genes and transgenic plants and plant cells containing those genes. More particularly, the nuclear fertility restorer genes can be used to restore fertility in cytoplasmic male-sterile plants such as Brassica napus. Preferably, the nuclear fertility restorer genes are used with the Ogura (ogu) CMS system in Brassica napus.
Inventor(s): Brown; Gregory G. (Montreal, CA), Dendy; Charles (St. Luc, CA), Landry; Benoit S. (L\'Acadie, CA), Cheung; Wing (Brossard, CA), Jin; Hua (St-Jean-sur-Richlieu, CA), Lai; Fang-Ming (Apex, NC), Formanova; Natasa (Montreal, CA), LaForest; Martin (St-Luc, CA)
Assignee: BASF Plant Science GmbH (Research Triangle Park, NC)
Application Number:10/345,072
Patent Claims:1. A method of identifying a transformed Brassica plant, comprising the steps of: a) providing an expression cassette comprising a radish genomic DNA that encodes a male fertility restorer protein having a sequence comprising amino acids 1 to 687 of SEQ ID NO:179; b) introducing said expression cassette into cells of a cytoplasmically male sterile Brassica plant; c) regenerating Brassica plants from said cells; and d) identifying a Brassica plant from step c) that forms seeds by self-pollination, thereby identifying the transformed Brassica plant.

2. The method of claim 1, wherein said plant is Brassica napus.

3. The method of claim 1, wherein said expression cassette is covalently linked to a sequence of interest.

4. The method of claim 1, wherein said expression cassette is cotransformed into said plant cells with a sequence of interest.

5. A method of identifying a transformed Brassica plant, comprising the steps of: a) providing an expression cassette comprising a radish genomic DNA that encodes a male fertility restorer protein having a sequence comprising amino acids 1 to 687 of SEQ ID NO:179; b) introducing said expression cassette into cytoplasmically male sterile Brassica plants; and c) identifying a Brassica plant from step b) that forms seeds when self-pollinated, thereby identifying the transformed Brassica plant.

6. The method of claim 5, wherein said plant is Brassica napus.

7. The method of claim 5, wherein said expression cassette is covalently linked to a sequence of interest.

8. The method of claim 5, wherein said expression cassette is cotransformed into said plant cells with a sequence of interest.

9. An isolated nucleic acid selected from the group consisting of: a) an open reading frame encoding an Rfo protein, said open reading frame being contained within genomic DNA having a sequence comprising nucleotides 167,079 to 173,669 of SEQ ID NO:87, wherein nucleotides 167,459 to 167,585 represent an intron; b) a full-length complement of a) and c) a nucleic acid comprising a nucleotide sequence differing from the sequence of the nucleic acids of a) or b) due to the degeneracy of the genetic code.

10. The nucleic acid of claim 9, wherein the open reading frame encodes the Rfo protein having a sequence comprising amino acids 1 to 687 of SEQ ID NO:179.

11. An isolated radish genomic nucleic acid comprising a gene encoding a protein having a sequence comprising amino acids 1 to 687 of SEQ ID NO:179.

12. An isolated nucleic acid comprising nucleotides 164,311 to 174,022 of SEQ ID NO:87.

13. The full-length complement of the nucleic acid of claim 12.

14. A Brassica plant transformed with an isolated nucleic acid selected from the group consisting of: a) an open reading frame encoding an Rfo protein, said open reading frame being contained within genomic DNA having a sequence comprising nucleotides 167,079 to 173,669 of SEQ ID NO:87, wherein nucleotides 167,459 to 167,585 represent an intron; b) a full-length complement of a); and c) a nucleic acid comprising a nucleotide sequence differing from the sequence of the nucleic acids of a) or b) due to degeneracy of the genetic code.

15. The plant of claim 14, wherein the nucleic acid is an open reading frame contained within the genomic DNA having the sequence comprising nucleotides 167,079 to 173,669 of SEQ ID NO:87, and wherein nucleotides 167,459 to 167,585 represent an intron.

16. The plant of claim 14, wherein the nucleic acid encodes a protein having a sequence comprising amino acids 1 to 687 of SEQ ID NO:179.

17. The plant of claim 14, wherein the nucleic acid is the full-length complement of the open reading frame contained within the genomic DNA having the sequence comprising nucleotides 167,079 to 173,669 of SEQ ID NO:87, and wherein nucleotides 167,459 to 167,585 represent an intron.

18. A Brassica plant transformed with an expression vector comprising an isolated nucleic acid having a sequence comprising nucleotides 164,311 to 174,022 of SEQ ID NO:87.

Details for Patent 7,314,971

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2021-07-12
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2021-07-12
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2021-07-12
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.